A First-in-Human Study of RGT-075, a Novel, Orally Bioavailable, Small-Molecule GLP-1 Receptor Agonist, in Healthy Adult Subjects

被引：0
|
作者：
Pirner, Mark A.
Lin, Jing
Liu, Feng
Yao, Lili
Zettler, Marjorie E.
Valacer, David J.
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-724-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
724-P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Oral Small Molecule GLP-1 Receptor Agonist (HRS-7535) in Healthy Subjects -A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Dose Study
    Wu, Jingying
    Hu, Wei
    Du, Yijun
    Zhang, Qian
    Zhou, Renpeng
    Zhang, Qin
    Qin, Huiling
    Ye, Zi
    Xu, Yimei
    Feng, Sheng
    Shu, Chang
    Shen, Yu
    Fan, Yang
    DIABETES, 2023, 72
  • [32] Safety and Blood Pressure Lowering Effects of a Novel and Long-Acting Natriuretic Peptide Receptor 1 Agonist in Healthy Participants: A First-in-Human Clinical Study
    He, YanLing
    Wu, Xueping
    Roma, Andre Serra
    Markiewicz, Maggie
    Healy, Emma
    Yan, Jing-He
    Bitsaktsis, Constantine
    Kulmatycki, Kenneth
    Kinhikar, Arvind
    Zhang, Tong
    Yates, Denise
    Frost, Robert
    Nguyen, David
    Russo, Cesare
    ODonnell, Christopher J.
    CIRCULATION, 2023, 148 (25) : E301 - E301
  • [33] Pharmacokinetics, Pharmacodynamics, and Safety of HD-6277, a Selective Agonist of G-Protein-Coupled Receptor 40, in Healthy Subjects as a First-in-Human Study
    Kim, Ki-Hwan
    Kim, Pan-Kyung
    Yang, Hye-Jung
    DIABETES, 2019, 68
  • [34] A first-in-human study of NOV1601 (CHC2014), small-molecule inhibitor of TRK family proteins, in adult patients with solid organ malignancies
    Yun, T.
    Moon, Y. W.
    Shin, S. J.
    Kim, D-W.
    Yun, C. H.
    You, J. Y.
    Hyun, B.
    Cho, H. W.
    Kim, J. S.
    Im, G.
    Kim, Y.
    Park, N.
    ANNALS OF ONCOLOGY, 2020, 31 : S502 - S502
  • [35] First-in-human dose-escalating study of ABSK043, a novel and oral small-molecule inhibitor of PD-L1, in patients with advanced solid tumors
    Cooper, A.
    Andelkovic, V.
    Wilkinson, K.
    Ganju, V.
    Lundy, J.
    Hong, M.
    Airey, S.
    Meng, L. L.
    Shen, B.
    Li, H.
    Yao, L.
    Zhang, M.
    Coward, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S487 - S487
  • [36] A first-in-human phase 1 study of ACE910, a novel factor VIII-mimetic bispecific antibody, in healthy subjects
    Uchida, Naoki
    Sambe, Takehiko
    Yoneyama, Koichiro
    Fukazawa, Naoki
    Kawanishi, Takehiko
    Kobayashi, Shinichi
    Shima, Midori
    BLOOD, 2016, 127 (13) : 1633 - 1641
  • [37] Preclinical, toxicological and safety assessments of MOD-6031, a novel long-acting GLP-1/Glucagon agonist, support Phase 1 study in healthy overweight and obese subjects
    Hart, G.
    Israeli-Yagev, L.
    Bar-Ilan, A.
    Lev, V.
    Hershkovitz, O.
    DIABETOLOGIA, 2016, 59 : S316 - S316
  • [38] First-in-Human Studies to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Novel 5-HT4 Partial Agonist, SUVN-D4010, in Healthy Adult and Elderly Subjects
    Ramakrishna Nirogi
    Gopinadh Bhyrapuneni
    Nageswara Rao Muddana
    Vinod Kumar Goyal
    Santosh Kumar Pandey
    Abdul Rasheed Mohammed
    Jyothsna Ravula
    Satish Jetta
    Veera Raghava Chowdary Palacharla
    Clinical Drug Investigation, 2021, 41 : 469 - 482
  • [39] First-in-Human Studies to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Novel 5-HT4 Partial Agonist, SUVN-D4010, in Healthy Adult and Elderly Subjects
    Nirogi, Ramakrishna
    Bhyrapuneni, Gopinadh
    Muddana, Nageswara Rao
    Goyal, Vinod Kumar
    Pandey, Santosh Kumar
    Mohammed, Abdul Rasheed
    Ravula, Jyothsna
    Jetta, Satish
    Palacharla, Veera Raghava Chowdary
    CLINICAL DRUG INVESTIGATION, 2021, 41 (05) : 469 - 482
  • [40] GL0034 (Utreglutide), a novel, long acting, glucagon-like peptide 1 receptor agonist (GLP-1 RA), results of a phase 1 study in healthy individuals
    Thennati, Rajamannar
    Burade, Vinod
    Natarajan, Muthukumaran
    Shahi, Pradeep
    Nagaraja, Ravishankara
    Panchal, Satish
    Agrawal, Sudeep
    Jandrain, Bernard
    Duvauchelle, Thierry
    Pratley, Richard E.
    Thorens, Bernard
    Vilsboll, Tina
    JOURNAL OF HEPATOLOGY, 2023, 78 : S607 - S608
12345